ArticleCancer chemotherapy and pharmacology2014

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.

Heyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.